Government Aims to Expand Investigations on Current Wholesale Transaction Practices

In light of a recent discovery of counterfeit antihypertensive Novarsc medications that contain no therapeutic efficacy, the Korea Food and Drug Administration (KFDA) plans to undertake a joint investigative effort with the government prosecutors to examine current wholesale transaction practices by the domestic pharmaceutical wholesalers.

Upon discovery of counterfeit Novarsc medications, t...